Cargando…
miR-140-3p Inhibits Cutaneous Melanoma Progression by Disrupting AKT/p70S6K and JNK Pathways through ABHD2
Because cutaneous melanoma (CM) is one of the most lethal human tumors, major treatment advances are vital. miR-140-3p has been suggested to act as a suppressor in a range of malignant tumors, implying its possible use as a biomarker for effective antineoplastic treatment. However, the potential rol...
Autores principales: | He, Yuanmin, Yang, Yan, Liao, Yongmei, Xu, Jixiang, Liu, Li, Li, Changqiang, Xiong, Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7163049/ https://www.ncbi.nlm.nih.gov/pubmed/32322665 http://dx.doi.org/10.1016/j.omto.2020.03.009 |
Ejemplares similares
-
Retraction Notice to: miR-140-3p Inhibits Cutaneous Melanoma Progression by Disrupting AKT/p70S6K and JNK Pathways through ABHD2
por: He, Yuanmin, et al.
Publicado: (2023) -
IL22 drives cutaneous melanoma cell proliferation, migration and invasion through activation of miR-181/STAT3/AKT axis
por: He, Yuanmin, et al.
Publicado: (2020) -
miR-140-5p and miR-140-3p: Key Actors in Aging-Related Diseases?
por: Toury, Léa, et al.
Publicado: (2022) -
Dysregulation of both miR-140-3p and miR-140-5p in synovial fluid correlate with osteoarthritis severity
por: Yin, C-M., et al.
Publicado: (2017) -
Immunomodulatory lysophosphatidylserines are regulated by ABHD16A and ABHD12 interplay
por: Kamat, Siddhesh S., et al.
Publicado: (2015)